Efficacy and Safety of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study
Author:
Affiliation:
1. Department of Child and Adolescent Psychiatry, Hokkaido University Hospital, Sapporo, Japan.
2. Sumitomo Dainippon Pharma Co., Ltd., Chuo-ku, Tokyo, Japan.
3. Institute of CNS Pharmacology, Shibuya-ku, Tokyo, Japan.
Publisher
Mary Ann Liebert Inc
Subject
Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health
Link
https://www.liebertpub.com/doi/pdf/10.1089/cap.2021.0013
Reference34 articles.
1. Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth
2. Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
3. Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis
4. A systematic review of the long-term outcome of early onset schizophrenia
5. Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Temporal trends in antipsychotic prescriptions for pediatric patients using an administrative hospital database in Japan: a retrospective study;Journal of Pharmaceutical Health Care and Sciences;2024-01-02
2. Efficacy and safety of blonanserin versus risperidone in the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials;BMC Psychiatry;2023-10-11
3. Safety and effectiveness of oral blonanserin for schizophrenia in adolescents in China: Data from a 12-week post-marketing surveillance;The European Journal of Psychiatry;2023-10
4. Narrative review of the advances in the pharmacotherapeutic management of juvenile-onset schizophrenia;Expert Opinion on Pharmacotherapy;2023-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3